Smoking and respiratory diseases in patients with coronary microvascular dysfunction.

COPD Interventional Cardiology MINOCA Pulmonary Risk Factors Smoking

Journal

The American journal of medicine
ISSN: 1555-7162
Titre abrégé: Am J Med
Pays: United States
ID NLM: 0267200

Informations de publication

Date de publication:
12 Mar 2024
Historique:
received: 08 10 2023
revised: 18 01 2024
accepted: 18 02 2024
medline: 15 3 2024
pubmed: 15 3 2024
entrez: 14 3 2024
Statut: aheadofprint

Résumé

Coronary microvascular disease (CMD) is common in patients with and without obstructive coronary artery disease, and is associated with adverse clinical outcomes. Respiratory-related variables are associated with pulmonary and systemic microvascular dysfunction, while evidence regarding their relationship with CMD is limited. We aim to evaluate respiratory-related variables as risk factors of CMD. This is an observational, single-center study enrolling consecutive patients undergoing invasive evaluation of coronary microvascular function in the catheterization laboratory. Patients with evidence of obstructive coronary artery disease or with missing data were excluded. Associations between respiratory related variables and indices of CMD were assessed using univariate and multivariate regression models. Overall, 266 patients (mean age 67 ±11, 59% females) were included in the current analysis. Of those, 155 (58%) had evidence of CMD. Among the respiratory variables, independent predictors of CMD were current smoking (adjusted OR 2.5, 95% CI 1.2-5, p=0.01) and obstructive sleep apnea (AOR 5.7, 95% CI 1.2-26, p=0.03), while chronic obstructive pulmonary disease was not. Among ever-smokers, higher smoking pack-years was an independent risk factor for CMD (median 35 vs. 25 pack years, AOR 1.09, 95% CI 1.04-1.13, p<0.01), and was associated with higher rates of pathologic index of microcirculatory resistance (IMR) and resistive reserve ratio (RRR). In patients undergoing invasive coronary microvascular evaluation, current smoking and obstructive sleep apnea are independently associated with CMD. Among smokers, higher pack-years is a strong predictor for CMD. Our findings should raise awareness for prevention and possible treatment options.

Sections du résumé

BACKGROUND BACKGROUND
Coronary microvascular disease (CMD) is common in patients with and without obstructive coronary artery disease, and is associated with adverse clinical outcomes. Respiratory-related variables are associated with pulmonary and systemic microvascular dysfunction, while evidence regarding their relationship with CMD is limited. We aim to evaluate respiratory-related variables as risk factors of CMD.
METHODS METHODS
This is an observational, single-center study enrolling consecutive patients undergoing invasive evaluation of coronary microvascular function in the catheterization laboratory. Patients with evidence of obstructive coronary artery disease or with missing data were excluded. Associations between respiratory related variables and indices of CMD were assessed using univariate and multivariate regression models.
RESULTS RESULTS
Overall, 266 patients (mean age 67 ±11, 59% females) were included in the current analysis. Of those, 155 (58%) had evidence of CMD. Among the respiratory variables, independent predictors of CMD were current smoking (adjusted OR 2.5, 95% CI 1.2-5, p=0.01) and obstructive sleep apnea (AOR 5.7, 95% CI 1.2-26, p=0.03), while chronic obstructive pulmonary disease was not. Among ever-smokers, higher smoking pack-years was an independent risk factor for CMD (median 35 vs. 25 pack years, AOR 1.09, 95% CI 1.04-1.13, p<0.01), and was associated with higher rates of pathologic index of microcirculatory resistance (IMR) and resistive reserve ratio (RRR).
CONCLUSION CONCLUSIONS
In patients undergoing invasive coronary microvascular evaluation, current smoking and obstructive sleep apnea are independently associated with CMD. Among smokers, higher pack-years is a strong predictor for CMD. Our findings should raise awareness for prevention and possible treatment options.

Identifiants

pubmed: 38485108
pii: S0002-9343(24)00134-7
doi: 10.1016/j.amjmed.2024.02.034
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ophir Freund (O)

Institute of pulmonary medicine, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel; Department of Internal Medicine B, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Aviel Shetrit (A)

Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Amir Bar-Shai (A)

Institute of pulmonary medicine, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Lior Zornitzki (L)

Department of Internal Medicine B, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel; Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Shir Frydman (S)

Department of Internal Medicine B, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel; Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Ariel Banai (A)

Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Reut Amar Shamir (RA)

Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Jeremy Ben-Shoshan (J)

Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Yaron Arbel (Y)

Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Shmuel Banai (S)

Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel.

Maayan Konigstein (M)

Department of Cardiology, Tel Aviv Sourasky Medical Center, and Tel Aviv University School of Medicine, Israel. Electronic address: Maayan.konigstein@gmail.com.

Classifications MeSH